ClinicalTrials.gov record
Completed No phase listed Observational

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)

ClinicalTrials.gov ID: NCT03189875

Public ClinicalTrials.gov record NCT03189875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS): Prospective Observational Cohort of Patients With Moderate-to-severe SLE to Characterize Cross-sectional and Longitudinal Disease Activity, Treatment Patterns and Effectiveness, Outcomes and Comorbidities, Healthcare Resource Utilization, and the Impact of SLE on Quality of Life by Type I Interferon Expression

Study identification

NCT ID
NCT03189875
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
830 participants

Conditions and interventions

Interventions

  • Standard of Care Other

Other

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2017
Primary completion
Nov 17, 2022
Completion
Nov 17, 2022
Last update posted
Feb 27, 2024

2017 – 2022

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
Research Site Phoenix Arizona 85037
Research Site Tucson Arizona 85724
Research Site Jonesboro Arkansas 72401
Research Site Beverly Hills California 90211
Research Site El Cajon California 92020
Research Site Loma Linda California 92354
Research Site Los Alamitos California 90720-5403
Research Site Los Angeles California 90095
Research Site Mission Viejo California 92691
Research Site San Francisco California 94143
Research Site West Hills California 91307
Research Site Miami Florida 33126
Research Site Tamarac Florida 33321
Research Site Coeur d'Alene Idaho 83814
Research Site Chicago Illinois 60612
Research Site Indianapolis Indiana 46202
Research Site Baltimore Maryland 21218
Research Site Baltimore Maryland 21286
Research Site Detroit Michigan 48202
Research Site Nashua New Hampshire 03060
Research Site Newark New Jersey 07103
Research Site Great Neck New York 11021
Research Site The Bronx New York 10461
Research Site Durham North Carolina 27710
Research Site Greensboro North Carolina 27408
Research Site Salisbury North Carolina 28144
Research Site Duncansville Pennsylvania 16635
Research Site Pittsburgh Pennsylvania 15232
Research Site Dallas Texas 75231
Research Site The Woodlands Texas 77382
Research Site Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03189875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03189875 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →